ProQR Therapeutics
PRQR
PRQR
51 hedge funds and large institutions have $17.2M invested in ProQR Therapeutics in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
39% less capital invested
Capital invested by funds: $28.2M → $17.2M (-$11M)
Holders
51
Holding in Top 10
–
Calls
$95K
Puts
$8K
Top Buyers
| 1 | +$862K | |
| 2 | +$653K | |
| 3 | +$252K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$245K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$162K |
Top Sellers
| 1 | -$6.35M | |
| 2 | -$2.79M | |
| 3 | -$478K | |
| 4 |
Millennium Management
New York
|
-$458K |
| 5 |
CAC
Cowen and Company
New York
|
-$342K |